CLLS - Cellectis S.A.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
11,626
12,731
25,187
42,584
55,043
Cost of Revenue
6,421
2,739
2,620
1,688
2,706
Gross Profit
5,205
9,992
22,567
40,896
52,337
Operating Expenses
Research Development
83,002
76,567
79,227
74,565
57,300
Selling General and Administrative
44,746
47,248
44,750
41,258
29,778
Total Operating Expenses
119,592
115,083
115,217
104,857
82,865
Operating Income or Loss
-114,387
-105,091
-92,650
-63,960
-30,527
Interest Expense
-
46
4
6
23
Total Other Income/Expenses Net
-
10,507
-16,549
599
7,141
Income Before Tax
-100,153
-88,332
-103,683
-63,917
-22,273
Income Tax Expense
-
0
0
0
0
Income from Continuing Operations
-100,153
-88,332
-103,683
-63,917
-22,273
Net Income
-87,971
-78,693
-99,368
-63,918
-22,461
Net Income available to common shareholders
-87,971
-78,693
-99,368
-63,918
-22,461
Reported EPS
Basic
-
-1.93
-2.78
-1.81
-0.66
Diluted
-
-1.93
-2.78
-1.81
-0.66
Weighted average shares outstanding
Basic
-
40,774
35,691
35,290
34,150
Diluted
-
41,286
35,715
35,812
34,523
EBITDA
-
-85,909
-100,308
-61,810
-20,342